Navigation Links
New Hip Implant Provides Personalized Fit

WARSAW, Ind., March 11 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting.  The Continuum Cup combines the best of Zimmer's proven hip technologies – Trabecular Metal™ Technology, Metasul® Metal-on-Metal technology, BIOLOX® delta and Longevity® Highly Crosslinked Polyethylene – with new innovations in what is now the company's most versatile acetabular cup system.  

Candidates for hip replacement surgery represent a wide array of ages and lifestyle demands. Different patient circumstances require surgeons to consider a variety of implant bearing surfaces to accommodate their patients' needs.  The Continuum Cup gives surgeons the option of choosing between metal or Highly Crosslinked Polyethylene bearing surfaces, and metal or ceramic heads to match a range of patient lifestyles.  

"By creating a system with multiple cup liner options in a range of sizes and configurations, surgeons are able to select the cup and bearing surface which best meet each patient's specific needs, creating a more personalized fit," said Jeff McCaulley, President, Zimmer Reconstructive.  "In combination with our comprehensive stem portfolio, including our Fitmore® Hip Stem and our M/L Taper with Kinectiv® technology, Zimmer offers surgeons tremendous flexibility and confidence to personalize the implant solution."

Continuum shells are made with Zimmer's proprietary Trabecular Metal Technology, a highly porous tantalum material that supports initial implant stability and fixation.  Trabecular Metal Technology is conducive to more normal bone formation and bone in-growth, decreased stress-shielding, and the potential for improved long-term implant fixation.  The Metasul liner incorporates Zimmer's Metasul Metal-on-Metal technology, which has more than 20 years of clinical history.  Longevity, the principal technology behind the polyethylene liner, is highly resistant to wear and aging and has more than 10 years of clinical experience.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.

Back to top



SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GelFix(TM) Posterior Spinal Distraction Implant Receives CE Mark
2. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
3. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
4. AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators
5. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
6. WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
7. FDA Advisory Panel Votes 15 to 0 in Favor of Approving Envoy Medicals Esteem(R) Fully Implantable Hearing Restoration System
8. Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009
9. Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly
10. Reportlinker Adds European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries)
11. LifeNet Health Announces First Bio-Implant with New Preservation Technology
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):